M&A Corner
Bionoid Pharma Announces Letter of Intent to Acquire Global Alerts Corp.27 Mar 2023
Bionoid Pharma, Inc. has signed a Letter of Intent to acquire all the outstanding shares of Global Alerts Corp. The... Continue Reading
|
Mindstrong Sells Tech Assets to SonderMind, Shuts Down Operations27 Mar 2023
Digital mental health company SonderMind has acquired technology assets from fellow mental health firm Mindstrong, which recently shuttered its headquarters... Continue Reading
|
Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, The Functional Cell Biology Company27 Mar 2023
Berkeley Lights, Inc. has completed its acquisition of Isoplexis Corporation, and the two companies have been combined to create PhenomeX,... Continue Reading
|
Ally Biotech Announces Acquisition of Popular THC “Chill Pill” Soft Gel Cap Line from Desert Medical Campus, Inc.27 Mar 2023
Ally Biotech has announced the acquisition of the Chill Pill brand, a popular line of soft gel capsules, in an... Continue Reading
|
Casi Pharmaceuticals Completes Redomiciliation Merger27 Mar 2023
CASI Pharmaceuticals has completed its redomiciliation merger to become a Cayman Islands company. As a result of the merger, each... Continue Reading
|
Australia’s Estia Health Surges After $517.7 mln Bid from Bain Capital27 Mar 2023
On Friday, Estia Health Ltd, an Australian aged-care provider, announced that it has received a non-binding buyout proposal from US... Continue Reading
|
SAIC Unloads Logistics & Supply Chain Business Through Sale to ASRC Federal for $350M27 Mar 2023
Science Applications International (NYSE:SAIC) has announced the sale of its logistics and supply chain management business to ASRC Federal for... Continue Reading
|
Australian Clinical Labs Offers to Buy Healius for $1 Bln27 Mar 2023
Australian Clinical Labs has offered to acquire medical center operator Healius through an all-share takeover, valuing the company at $1.02... Continue Reading
|
Highmark Health Reaches $26 Billion in Revenue27 Mar 2023
Highmark Health has reported its financial results for the 2022 fiscal year, with $26 billion in revenue, an operating gain... Continue Reading
|
Resilience Approved for $410M Financing From The Department Of Defense, In Partnership With The Development Finance Corporation, To Establish Resilient Biomanufacturing Capacity27 Mar 2023
National Resilience, a biomanufacturing company focused on expanding access to complex medicines, has secured $410 million in long-term loan financing... Continue Reading
|